Document Detail

Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
MedLine Citation:
PMID:  20932108     Owner:  NLM     Status:  In-Process    
Statin therapy reduces the risk of cardiovascular events in patients with coronary artery disease. Recent in vitro and in vivo studies demonstrated a LDL-independent action of these class of drugs, which appears in modulating endothelial function, inflammation and thrombosis. Periprocedural myocardial infarction and contrast-induced nephropathy after percutaneous coronary intervention (PCI), associated with worse outcome on long-term follow-up, are both complications related to inflammatory pathogenetic mechanisms. Randomized studies demonstrated a beneficial effect of short-term statin pretreatment in reducing periprocedural cardiac marker release in patients undergoing PCI. Statin therapy before elective PCI reduces periprocedural myocardial infarction in patients with stable angina. Furthermore, an acute loading with a high dose of atorvastatin prevents myocardial damage in patients with acute coronary syndromes undergoing early PCI (<48 h). In patients already on chronic statin therapy, a reload with high-dose statins was associated with a significant improvement on 30-day major adverse cardiac event rates. Furthermore, statin therapy at the time of PCI significantly decreased the incidence of contrast-induced nephropathy. This evidence suggests an 'upstream administration' of short-term, high-dose statins in all patients undergoing PCI.
Annunziata Nusca; Rosetta Melfi; Giuseppe Patti; Germano Di Sciascio
Related Documents :
23129588 - Chronic depletion of glutathione exacerbates ventricular remodeling and dysfunction in ...
23074608 - Signal-averaged electrocardiography in patients with advanced heart failure: a better i...
24749108 - Topcat misses its primary endpoint: should spironolactone be abandoned in hfpef?
23514988 - Insights into atrial fibrillation.
25352208 - Cardiac calcium score on 2d echo: correlations with cardiac and coronary calcium at mul...
12843688 - Angiotensin-receptor blockers: revival of the systemic prevention of restenosis?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Future cardiology     Volume:  6     ISSN:  1744-8298     ISO Abbreviation:  Future Cardiol     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101239345     Medline TA:  Future Cardiol     Country:  England    
Other Details:
Languages:  eng     Pagination:  579-89     Citation Subset:  IM    
Campus Bio-medico, University of Rome, Via Alvaro del Portillo 200, 00218, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity follow...
Next Document:  Hemodynamically complicated ST-segment elevation myocardial infarction: presentation and treatment.